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Abstract
The brucellae are a-Proteobacteria facultative intracellular parasites that cause an important zoonosis. These bacteria escape
early detection by innate immunity, an ability associated to the absence of marked pathogen-associated molecular patterns
in the cell envelope lipopolysaccharide, lipoproteins and flagellin. We show here that, in contrast to the outer membrane
ornithine lipids (OL) of other Gram negative bacteria, Brucella abortus OL lack a marked pathogen-associated molecular
pattern activity. We identified two OL genes (olsB and olsA) and by generating the corresponding mutants found that olsB
deficient B. abortus did not synthesize OL or their lyso-OL precursors. Liposomes constructed with B. abortus OL did not
trigger IL-6 or TNF-a release by macrophages whereas those constructed with Bordetella pertussis OL and the olsB mutant
lipids as carriers were highly active. The OL deficiency in the olsB mutant did not promote proinflammatory responses or
generated attenuation in mice. In addition, OL deficiency did not increase sensitivity to polymyxins, normal serum or
complement consumption, or alter the permeability to antibiotics and dyes. Taken together, these observations indicate
that OL have become dispensable in the extant brucellae and are consistent within the trend observed in a-Proteobacteria
animal pathogens to reduce and eventually eliminate the envelope components susceptible of recognition by innate
immunity.
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Introduction
The members of the genus Brucella are a-2 Proteobacteria that
cause brucellosis, an important disease affecting livestock and wild
life as well as human beings. These bacteria trigger only low
proinflammatory responses in the initial stages of infection and,
accordingly, they follow a stealthy behavior that allows them to
reach sheltered intracellular niches before effective immunity
activation. The outer membranes (OM) of brucellae are of critical
importance in this strategy. Whereas most gram-negative have
OM molecules bearing the pathogen-associated molecular pat-
terns (PAMP) recognized by innate immunity, at least the Brucella
OM lipopolysaccharide (LPS), lipoproteins and flagellin display a
reduced PAMP [1,2]. Moreover, smooth (S) brucellae such as B.
abortus and B. melitensis have OMs that are unusually resistant to the
disrupting action of bactericidal peptides and complement. Thus,
periplasmic and internal PAMP-bearing molecules like peptido-
glycan or DNA are not readily accessible to pathogen recognition
receptors [1,3–8]. The Brucella LPS is clearly implicated in these
properties and there is evidence that other lipid molecules also
contribute. Brucella OMs contain large amounts of phosphatidyl-
choline (PC) and blockage of the synthesis of PC with the
subsequent replacement by phosphatidylethanolamine (PE) gen-
erates attenuation [9,10]. Ornithine lipids (OLs) are present in
relatively large amounts in Brucella [11] and, although they have
interesting properties in other bacteria, have not been investigated.
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It has been reported that Pseudomonas fluorescens grown under
conditions that increase OL content becomes more resistant to the
polycationic lipopeptide polymyxin B indicating a connection
between these amino lipids and the resistance to bactericidal
peptides [12,13]. Moreover, OLs of Bordetella pertussis, Flavobacterium
meningosepticum and Achromobacter xylosoxidans display antagonistic
effects on LPS endotoxicity as well as proinflammatory and
inflammatory activity [14–18]. Such an activity in Brucella OL
would be in apparent contradiction with the furtive behavior of
these bacteria with respect to innate immunity. Therefore, it was
of interest to know whether Brucella OLs play a role in the OM
stability and resistance to polycations and whether they display a
biological activity different from that of other OLs, including the
evasion of pathogen recognition receptors.
Results
OLs are OM components of B. abortus
To determine the cellular localization of OLs, we first examined
the free-lipids in virulent S B. abortus 2308 NalR grown in tryptic
soy broth to the stationary phase, in the OM fragments released
spontaneously during growth [19] and in non-delipidated B. abortus
LPS [20]. Thin-layer chromatography of the corresponding
chloroform:methanol:water extracts [21] confirmed the presence
of OLs in B. abortus and showed their enrichment in the OM
fragments (Figure 1 A), thus demonstrating that they are OM
components. Although in amounts lower than PE, OLs were also
detected in non-delipidated B. abortus LPS suggesting an
association in the OM (Figure 1 A). The levels of OLs did not
change when the bacteria were cultured in tryptic soy broth or in
Brucella Gerhardt’s minimal medium (lactate-glutamate-glycerol,
mineral salts, vitamins) [22] (Figure 1 A).
B. abortus OLs are synthesized through a two step
pathway
We searched the B. abortus 2308 genome for orthologs of the
genes involved in OL synthesis in other a-2 Proteobacteria. In
Sinorhizobium meliloti, OlsB acylates the ornithine a amino group
with C18:0(3-OH) and OlsA generates the acyloxyacyl group by
esterification with C18:0 (Figure 1 B) [23,24]. In Rhizobium tropici,
an additional gene (olsC) codes for an oxygenase that generates a 2-
hydroxy substitution on the ester-linked acyl group [25] (Figure 1
B). We found that ORF BAB1_0147 (annotated as encoding a
hypothetical protein) codes for a protein with 55% identity and
66% similarity with OlsB, and that the product of ORF
BAB1_2153 (annotated as a phospholipid-glycerol acyltransferase)
has 45% identity and 61% similarity with OlsA. Moreover, we
located similar ORFs in the genomes of B. melitensis 16M and B.
suis 1330 (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi).
ORF BAB1_0147 (henceforth BABolsB) maps as an isolated gene.
BAB1_2153 (henceforth BABolsA) is in a possible operon formed
by at least BAB1_2151 (putative glycoprotease), BAB1_2152
(putative acetyltransferase) and probably by BAB1_2154 (hypo-
thetical protein; the stop codon of BAB1_2152 and the start codon
of BAB1_2153 overlap). Both BABOlsA and BABOlsB contain a
sequence [H73 (X)4 D78 and H76 (X)4 D81, respectively] that
could correspond to the consensus motif [H(X)4D] of glycerolipid
acyltransferases [26]. Moreover, BABOlsA contains two regions,
NHTS (amino acids 72–75) and AEGTT (amino acids 143–147),
closely resembling the NHQS and PEGTR motifs highly
conserved in lysophosphatidic acid acyltransferases [27]. We also
found a DNA sequence with homology to olsC. However, the
possible BABolsC carried a frame shift in the same position in all
accessible B. abortus, B. melitensis and B. suis genomes so that it
corresponds to two ORF (annotated as BMEI0464 and
BMEI0465 in B. melitensis 16M). Amino acids 1 to 155 of
BMEI0464 have a 87% identity (92% homology) with amino acids
31 to 185 of S. meliloti OlsC, and amino acids 1 to 94 of BMEI0465
are 87% identical (91% homology) to the 187 to 280 stretch of
OlsC [28]. Most of the consensus of the OslC-LpxO family of
proteins is in BMEI0464 but at the very end of the protein and
truncated in the last four amino acids, including the last isoleucine
conserved in all OlsC homologues [29]. All these characteristics
strongly suggest that the structure of Brucella OLs is similar to those
described previously for Rhodospseudomonas sphaeroides (Figure 1C).
Using the above-described evidence, we constructed internal in-
frame deletion mutants of the virulent B. abortus 2308 NalR strain
(henceforth BAB-parental) devoid of the consensus motifs following a
PCR overlap strategy [30] (Table S1). For BABolsB, we removed
amino acids 40 to 229, which resulted in a truncated protein of 107
amino acids (mutant BABDolsB). The deletion in BABolsA (mutant
BABDolsA) eliminated amino acids 48 to 245 and resulted in a
truncated protein of 69 amino acids. Figure 1 A shows that BABDolsA
lacked OLs but synthesized a new ninhydrin-positive component
corresponding to the lyso-ornithine lipid (lyso-OL) precursor [31]. In
contrast, the only ninhydrin-positive lipid generated by mutant
BABDolsB was PE. When we complemented mutant BABDolsB with
plasmid pLPI-6 (carrying BABolsB; Table S1), OL synthesis was
restored (Figure 1 A). Similarly, BABDolsA complemented with
plasmid pYLI-1 (carrying BABolsA) was able to produce OLs (not
shown). These results are consistent with a two step pathway in which
BABOlsB and BABOlsA act consecutively and where deletion of the
former abrogates OL and lyso-OL synthesis (Figure 1 B).
Characterization of mutants BABDolsA and BABDolsB showed
no change in colonial morphology, or in catalase, oxidase, and
urease activities. They were S according to lysis by B. abortus S-
specific phages, agglutination with anti-A and anti-M monospe-
cific sera, crystal violet exclusion and acriflavine agglutination test.
OLs are not required for Brucella OM resistance to
bactericidal peptides and complement
Due to the OL abundance in Brucella and their zwitterionic
nature, it has been proposed that they play a relevant role in the
stabilization of negative charges of LPS and, therefore, in the
stability of the OM [32]. To test this, we first examined the
sensitivity to bactericidal peptides. We found no significant
differences in the minimal inhibitory concentrations of polymyxin
B and colistin on BAB-parental, BABDolsA and BABDolsB strains.
Since bactericidal peptides are also OM permeabilizing agents, we
probed the mutants with polymyxin B plus lysozyme under
hypotonic conditions in comparison with Escherichia coli. This
treatment was effective in killing E. coli but had no action on
mutants BABDolsB or BABDolsA or on BAB-parental (Figure 2).
Moreover, EDTA alone or combined with polymyxin B did not
promote lysozyme uptake, proving that divalent cations were not
taking over the hypothetical role of OLs in OM stabilization
(Figure 2). Finally, sensitivity to a set of antibiotics (penicillin,
doxycycline, clarithromycin, erythromycin and rifampicin) that
penetrate the OM by hydrophilic or hydrophobic pathways, or of
dyes like thionine blue, fuchsine and safranin remained unchanged
(not shown). All these results indicate that OLs are neither
necessary to stabilize the OM of B. abortus against bactericidal
peptides nor influence its permeability.
B. abortus mutants altered in PC synthesis, with a truncated LPS
or an upset OM protein profile are sensitive to killing by non-
immune serum [33–35]. However, OL deficiency did not have a
similar effect because we observed only a small and not significant
(p.0.05) increase in serum sensitivity in mutant BABDolsB
Brucella Ornithine Lipids
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(Figure 3 A). Although small differences in antibody-independent
complement activation were suggested when large amounts of
bacteria were used (Figure 3 B), the differences were not
statistically significant (p.0.05). Finally, we also tested the surface
hydrophobicity of the mutants and the exposure of major OM
proteins. The partition coefficient of the wild type BAB-parental
Figure 1. Brucella abortus OLs are OM components synthesized in a two step pathway. (A). Thin layer chromatography analysis of total free-
lipid extracts of: (1), BAB-parental cells grown in tryptic soy broth; (2), OM fragments of BAB-parental; (3), BAB-parental crude LPS; (4) BAB-parental
grown in minimal medium; (5), BABDolsB cells; (6), BABDolsA cells; and (7), BABDolsB complemented with pLPI6. (B), proposed OL synthesis pathway
[adapted from [87]]. The identities of Brucella OL acyl chains are from reference [88] and the genetic evidence. (C), proposed structures of OL of
bacteria of various phylogenetic groups.
doi:10.1371/journal.pone.0016030.g001
Figure 2. B. abortus OL-deficient mutants are not sensitive to polymyxin B, lysozyme or EDTA. Late exponential phase bacterial
suspensions in HEPES (pH 7.5) were exposed to combinations of polymyxin B (100 units/ml), lysozyme (50 mg/ml) and EDTA (5 mM) and bacterial lysis
followed turbidimetrically.
doi:10.1371/journal.pone.0016030.g002
Brucella Ornithine Lipids
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and the BABDolsB mutant in water:hexadecane was similar and
widely different from that of an O-polysaccharide deficient B.
abortus per mutant used as a reference (Figure 3 C). Similarly,
Western-blot analysis of extracts of wild type BAB-parental and
BABDolsB cell envelopes did not show differences in the reactivity
of Omp 1, Omp2b, Omp31b, Omp25, Omp19, Omp16, and
Omp10 (not shown).
The absence of OLs does not influence proinflammatory
responses to B. abortus or the ability to multiply
intracellularly and generate chronic infections
Since B. abortus induces a negligible proinflammatory response
in mice at early times of infection [1], we examined whether the
lack of OLs could alter this property by examining several
markers. First, we tested the generation of fibrin D-dimer that
would result from the activation of the blood clothing cascade
caused by endotoxic microorganisms. For this, we infected Swiss
Webster mice 106 CFU/mouse of BAB-parental or mutant
BABDolsB (controls received 0.1 ml of 100 mM phosphate
buffered saline (pH 7.2) [PBS]) and examined the serum 24 h
later. For BAB-parental, the results confirmed previous reports [1]
on the absence of any increase in fibrin D-dimers above the
positive threshold (0.5 mg/ml). Similarly, infection with the OL-
deficient mutant did not have a significant effect on fibrin D-dimer
generation. Then, we determined the number of leukocytes in the
peritoneal fluid and blood of mice injected intraperitoneally with
106 CFU of BAB-parental or BABDolsB, 105 CFU of S. typhimurium
or 0.1 ml of PBS. Whereas the latter induced a leukocyte
peritoneal recruitment and a progressive reduction in blood
leukocyte numbers at later times, these linked effects were not
observed in BAB-parental or BABDolsB mutant infected mice
(Figure 4). Similarly, lymphocyte, neutrophil and monocyte
numbers in blood and peritoneal fluid did not reveal significant
differences in Brucella infected mice (Figure 5). We also measured
TNF-a, IL-6, IL-10 and IL-12p40 in the blood of the same
animals, and found that the normalized levels of these cytokines
were similar in BAB-parental and BABDolsB infections (Figure 6).
These levels were similar to and much lower than those reported
for B. abortus 2308 and S. typhimurium, respectively [1].
To complement the above-described studies, we tested the
ability of the BABDolsB OL-deficient mutant to multiply in cells
and to generate chronic infections. First, we infected bone marrow
derived macrophages, RAW 264.7 macrophages and HeLa cells
and monitored the intracellular survival of bacteria [36]. Figure 7
shows that the BABDolsB mutant retained the ability to multiply
intracellularly in all these cells. Then, we inoculated BALB/c mice
intraperitoneally with 56104 CFU/mouse of BABDolsB or of BAB-
parental. Two, 6, and 12 weeks later, the bacteria in the spleens
were counted, the identity of the isolates confirmed by PCR, and
the spleen weights recorded. The results showed that the parental
were practically identical throughout the experiment (average
log10 CFU 6 SD values for BABDolsB and BAB-parental,
respectively, were: week 2, 6.0960.24 and 6.2060.11; week 6,
6.6560.19 and 6.6960.32; and week 12: 5.8560.48 and
5.8060.46). Similarly, there were no splenomegaly differences
(0.3560.05 and 0.4060.04; 0.5860.06 and 0.5760.12;
0.4660.09 and 0.4360.12).
Consistent with the experiments in vitro, these observations
suggest that the absence of OLs does not affect the OM stability in
vivo and, accordingly, that OLs seem not to hamper the release of
PAMP-bearing molecules and the establishment of chronic
infections. Moreover, since BABDolsB did not promote a lower
or higher proinflammatory response than BAB-parental, the results
suggest that these lipids are neither detected by the pathogen
recognition receptors nor antagonists in the recognition of other
OM molecules during brucellosis.
B. abortus OL do not stimulate cytokine secretion in
murine macrophages
To test whether Brucella OLs carry a PAMP, we used the BAB-
parental and BABDolsB lipids, since the presence of PC in Brucella
allows obtaining stable liposomes. As a positive control, we extracted
the lipids of B. pertussis (containing OL but not PC) and generated B.
pertussis OL-liposomes using the OL-free lipids of BABDolsB as
carriers. After verification of the liposome composition (Figure 8 A),
we stimulated RAW 264.7 macrophages. While the B. pertussis-
BABDolsB liposomes notably stimulated TNF-a and IL-6 secretion,
the BAB-parental or BABDolsB liposomes were inactive (Figure 8 B).
Figure 3. B. abortus OL-deficient mutants do not show increased sensitivity to normal serum, complement activation activity or
altered surface hydrophobicity. (A), survival of BAB-parental and BABDolsB after 90 min of incubation in non-immune serum (B. abortus per- and
B. abortus BvrR- are mutants defective in the LPS O-polysaccharide or with an altered OM, respectively, that are sensitive to non-immune serum); (B),
packed bacteria were incubated with normal rabbit serum and the complement remaining measured as the hemolytic activity using an erythrocyte-
antibody system; (C), partition coefficients of of BAB-parental, BABDolsB, B. abortus per- in hexadecane and water. Data are the mean6 standard error
of triplicate measurements.
doi:10.1371/journal.pone.0016030.g003
Brucella Ornithine Lipids
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These results clearly show that Brucella OL, in contrast to those of B.
pertussis, do not bear a marked PAMP. In addition, they demonstrate
that Brucella phospholipids do not inhibit PAMP recognition.
Discussion
The OM of most gram negative bacteria hinders the
penetration of harmful molecules, and the LPS plays a key role
in this important property. The LPS inner sections (core
oligosaccharide and lipid A) are rich in acidic sugars and
orthophosphate, and these negatively charged groups bind
divalent cations and polyamines that bridge the LPS molecules
and hamper the partition of hydrophobic permeants into the OM
[37,38]. However, this supramolecular arrangement makes OM
sensitive to divalent cation chelators like EDTA and to bactericidal
peptides. Moreover, this set of properties is connected to the
PAMP of a variety of OM molecules, primarily the LPS.
Interestingly, Brucella OM is comparatively permeable to hydro-
phobic compounds and resistant to those agents. At least in part,
these properties are accounted for by a low number of negatively
Figure 4. B. abortus OL-deficient mutants do not trigger increased blood or peritoneal leukocyte responses during the early stages
of infection in mice. Mice were intraperitoneally injected with 106 CFU of BAB-parental or BABDolsB or with 105 CFU of S. typhimurium, total
leukocyte numbers determined at the indicated periods and values normalized with respect to the values in mice inoculated with PBS. Asterisks
indicate significant differences between S. typhimurium and the control (no significant differences were observed for the B. abortus strains).
doi:10.1371/journal.pone.0016030.g004
Figura 5. The OL-deficiency does alter not alter the profiles of lymphocytes, neutrophils and monocytes during the early stages of
B. abortus infection in mice. Lymphocyte, neutrophil and monocyte number is (A) blood and (B) peritoneum of mice intraperitoneally injected with
106 CFU of BAB-parental or BABDolsB (values normalized with respect to the values in mice inoculated with PBS).
doi:10.1371/journal.pone.0016030.g005
Brucella Ornithine Lipids
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charged groups which are limited to two 2-keto-3-doxyoctulosonic
acid residues and the lipid A phosphates [39–43]. Moreover, it was
proposed that the Brucella OLs could shield those negatively
charged groups by virtue of their positively charged amino groups,
as postulated for P. fluorescens [44]. Indeed, the results of this and
previous works in other bacteria [45–47] support that Brucella OLs
are in fact N-(acyloxyacyl)- ornithine OM structural elements with
a free amino group that should be positively charged at neutral
and acidic pH. Such an OL role would represent an advantage for
a pathogen because the hydrophobic anchorage should make OLs
more resistant than divalent cations to displacement by bacteri-
cidal peptides and proteins. However, since OL deficiency did not
increase the sensitivity of Brucella cells to polymyxins or the
permeability to lysozyme (a cationic peptide), this hypothesis was
disproved. Furthermore, any possible defect not detected by the in
vitro methods seems not to be relevant in vivo, at least in cells and
Figure 6. The OL-deficiency does not alter cytokine responses to B. abortus during the early stages of infection in mice. IL-6, IL-10, IL-
12p40 and TNF-a levels in the blood of mice intraperitoneally injected with 106 CFU of BAB-parental or BABDolsB (values normalized with respect to
the values in mice inoculated with PBS).
doi:10.1371/journal.pone.0016030.g006
Figure 7. The OL-deficiency does not alter the ability of B. abortus to multiply in mouse cells. (A), bone-marrow derived macrophages; (B),
RAW 264.7 macrophages; (C), Hela cells. Values are the mean 6 standard error of triplicate infections, and the results shown are representative of
three independent experiments.
doi:10.1371/journal.pone.0016030.g007
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mice. One possibility is that OLs are in the inner leaflet of the OM
and, therefore, not in contact with the polar moiety of the LPS. In
fact, our results suggest that PE (also with a free amino group) is
the more important LPS associated-lipid in B. abortus.
The interactions of OLs with innate immunity have been
analyzed in some c and b Proteobacteria. The OLs from B. pertussis
and A. xylosoxidans stimulate IL-1, TNF-a and prostaglandin E2
synthesis in macrophages [14,48–50]. Moreover, F. meningosepticum
OLs are mitogenic for B-lymphocytes and exhibit adjuvant activity
in C3H/HeJ mice, suggesting that receptors other than TLR4 are
involved in OL recognition [14,51,52]. Consistent with these
observations, OLs of B. pertussis presented in BABDolsB liposomes
triggered cytokine release. Therefore, the fact that this effect was
significantly lower when similar liposomes carried B. abortus OLs
demonstrates that innate immunity fails to efficiently recognize
these Brucella amino lipids. This is a well-known property of Brucella
LPS and other Brucella putative PAMP bearing molecules such as
flagella and lipoproteins and, therefore, our results extend this
ability to another OM element [1,53]. It is known that the acyl
groups in LPS, other glycolipids and synthetic aminolipids or
lipopeptides modulate the inflammatory activity [54–56] and,
indeed, the acyl chains of Brucella OL differ from those of other
bacteria in length and, in some cases, in the presence of a hydroxyl
group (Figure 1 C) [57–61]. In some bacteria, OL have ester-
linked fatty acyl groups with a hydroxyl group at the 2-position
and this hydroxyl group may affect the biological activity [62].
Figure 8. B. abortus OL do not stimulate TNF-a and IL-6 release in murine macrophages. Liposomes were made with the free lipid fraction
of BAB-parental, BABDolsB, or a mixture of B. pertussis and BABDolsB free lipids. (A), lipid composition of liposomes (aminolipids: ninhydrin staining;
total lipids: sulfuric acid charring); (B), IL-6 and TNF-a in the supernatants of RAW 264.7 macrophages after stimulation for 6 and 24 h with the
indicated liposomes.
doi:10.1371/journal.pone.0016030.g008
Brucella Ornithine Lipids
PLoS ONE | www.plosone.org 7 January 2011 | Volume 6 | Issue 1 | e16030
However, this hydroxylation is a post-synthesis modification that
requires OlsC, which is inactive in Brucella according to our
genomic analysis. All these data strongly suggest that the reduction
of Brucella OL PAMP is connected to the acyl chains, longer in
a-Proteobacteria than in other phylogenetic groups (Figure 1 C).
Indeed, these results add more weight to the hypothesis that
the hydrophobic moieties of Brucella OM elements are critical
in avoiding recognition of this pathogen by innate immunity
[1,8,63].
Here, we also presented evidence that Brucella OLs are
dispensable elements. Taking into account that Brucella OLs are
quantitatively important lipids, it is surprising that they are
dispensable. However, the a-Proteobacteria show a marked tendency
to live in tight interactions with eukaryotic cells [64] and there is
evidence that this ability is associated to a reduction in envelope
molecule PAMPs. Bartonella possess a low endotoxic LPS, a
reduced number of OM lipoproteins and flagellins that are not
recognized by TLR5 [65–67]. Similarly, Rickettsia carry a non
canonical LPS and a reduced number of lipoproteins [68], and
Wolbachia do not posses genes to synthesize LPS, flagella or
fimbriae, have a low number of lipoproteins and an unusual
peptidoglycan [69]. Finally, the genomes of Ehrlichia and Anaplasma
contain a low number of lipoprotein genes and do not have the
genetic machinery to synthesize LPS, peptidoglycan or flagellin
[70,71]. Accordingly, we hypothesize that free-living Brucella
ancestors carried OLs that were useful OM structural elements
in their environment but lost their importance once the major OM
target of immunity (i.e. the LPS) became adapted to the host. This
adaptation was marked by the modification in LPS PAMP
connected features (i.e., acyl chains and charged groups) and had
as a result that LPS no longer needed stabilizing agents in the OM.
Within this perspective, the degeneracy of the olsC homologue is in
keeping with the hypothesis that B. abortus OL represent
dispensable ancestral structures that could be eventually eliminat-
ed during the evolutionary process.
Materials and Methods
Ethics Statement
All animals were handled and sacrificed according to the
approval and guidelines established by the ‘‘Comite´ Institucional
para el Cuido y Uso de los Animales’’ of the Universidad de Costa
Rica, and in agreement with the corresponding law ‘‘Ley de
Bienestar de los Animales No 7451’’ of Costa Rica (http://www.
micit.go.cr/index.php/docman/doc_details/101-ley-no-7451-ley-
de-bienestar-de-los-animales.html).
BALB/c mice (Charles River, Elbeuf, France) were accommo-
dated in the animal building of the CITA of Arago´n (ID
registration number ES-502970012005) in cages with water and
food ad libitum and under biosafety containment conditions, for 2
weeks before the start and all along the experiment. The animal
handling and procedures were in accordance with the current
European legislation (directive 86/609/EEC) supervised by the
Animal Welfare Committee of the institution (protocol number
R102/2007).
Bacterial strain and growth conditions
Bacteria were grown in tryptic soy broth or agar either plain or
supplemented with kanamycin (Km) at 50 mg/ml, or/and nalidixic
(Nal) at 25 mg/ml, or/and gentamicin (Gm) at 20 mg/ml, or/and
chloramphenicol at 20 mg/ml (all from Sigma), or/and 5%
sucrose. Where indicated, the defined medium of Gerhardt [72]
was used. All strains were stored in skim milk at 280uC. The
origin of the B. abortus and S. typhimurium strains is described in
previous works [1,73,74]. B. pertussis is a clinical isolate kindly
provided by G. Martı´nez de Tejada.
Bacteriological procedures, antibiotic sensitivity and cell
surface characterization
The mutants were characterized according to standard Brucella
typing procedures [75]: colonial morphology after 3 days of
incubation at 37uC, crystal violet exclusion, catalase, oxidase,
urease, acriflavine agglutination, sensitivity to Tb, Wb, Iz and R/
C phages, agglutination with anti-A and anti-M monospecific sera,
CO2 and serum dependence, and susceptibility to thionine blue,
fuchsine, and safranin. Moreover, the minimal inhibitory concen-
trations of polymyxin B, colistin, penicillin, doxycycline, clarith-
romycin, erythromycin and rifampicin were determined in Mu¨ller-
Hinton medium by standard procedures.
Surface hydrophobicity was analyzed as described by Kupfer
and Zusman [76]. Bacteria were grown in tryptic soy broth until
stationary phase, incubated in 0.5% sodium azide at 37uC
overnight, collected by centrifugation (70006g, 10 min, 4uC),
washed twice with a solution of K2HPO4.3H20 97mM, KH2PO4
53mM, urea 21mM, MgSO4.7H2O 0.8mM and resuspended to
an OD470 = 1.0. A volume of 1.5 ml of this bacterial suspension
was mixed with 0.5ml of n-hexadecane and incubated during
10 min at 37uC. After shaking for 40 seconds, the tubes were
settled to allow phases separation to occur. The partition was
calculated as (12OD470 of water phase)/OD470 of the water
phase. Western-blot analysis with monoclonal antibodies to the
major Omps was carried out as described before [77].
DNA manipulations, construction of mutants and
complementation
Plasmid and chromosomal DNA were extracted with Qiaprep
spin Miniprep (Qiagen GmbH, Hilden, Germany), and Ultraclean
Microbial DNA Isolation kit (Mo Bio Laboratories) respectively.
When needed, DNA was purified from agarose gels using Qiack
Gel extraction kit (Qiagen). DNA sequencing analysis was
performed by the Servicio de Secuenciacio´n de DNA del Centro
de Investigacio´n Me´dica Aplicada (Navarra, Spain). Primers were
synthesized by Sigma-Genosys Ltd.. Searches for DNA and
protein homologies were carried out using the NCBI (National
Center for Biotechnology Information (http://www.ncbi.nlm.nih.
gov) and the EMBL-European Bioinformatics Institute server
(http://www.ebi.ac.UK/ebi_home.html). In addition, sequence
data were obtained from The Institute for Genomic Research at
http://www.tigr.org. Genomic sequences of B. melitensis 16M, B.
abortus and B. suis were analyzed using the database of the L’Unite´
de Recherche en Biologie Mole´culaire (URBM, Namur, Belgium)
(http://www.serine.urbm.fundp.ac.be/,seqbruce/GENOMES/
Brucella_melitensis).
For constructing the BABDolsB mutant, oligonucleotides olsB-F1
(59 -CTTCTGTCATCGTCGCGTAG- 39) and olsB-R2 (59-
GATGCGTCCCAGAATGATG-39) were used to amplify a
270-bp fragment including codons 1 to 39 of the olsB ORF, as
well as 153 bp upstream of the olsB first putative start codon, and
oligonucleotides olsB-F3 (59-CATCATTCTGGGACGCATCC-
CAAAGGAAGCGATCAACAA-39) and olsB-R4 (59- TTAAAA-
CCGGAACCGCTCTA- 39) were used to amplify a 294-bp
fragment including codons 230 to 297 of the olsB ORF and 87-bp
downstream of the olsB stop codon. Both fragments were ligated by
overlapping PCR using oligonucleotides olsB-F1 and olsB-R4 for
amplification, and the complementary regions between olsB-R2
and olsB-F3 for overlapping. The resulting fragment, containing
the olsB deletion allele, was cloned into pCR2.1 (Invitrogen), to
Brucella Ornithine Lipids
PLoS ONE | www.plosone.org 8 January 2011 | Volume 6 | Issue 1 | e16030
generate plasmid pIRI-2, sequenced to ensure the maintenance of
the reading frame, and subcloned into the BamHI and the XhoI
sites of the suicide plasmid pJQ200KS. The mutator plasmid
(pLRI-7) was introduced in BAB-parental by conjugation [78].
Integration of the suicide vector was selected by Nal and Gm
resistance, and the excision (generating the mutant strain by allelic
exchange) was selected by Nal and sucrose resistance and Gm
sensitivity. The resulting colonies were screened by PCR with
primers olsB-F1 and olsB-R4 which amplify a fragment of 564 bp
in the mutant and a fragment of 1134 bp in the parental strain.
The mutation resulted in the loss of the consensus amino acids
responsible for the enzymatic activity.
The BABDolsA mutant was constructed using primers olsA-F1
(59- GATTGCGCAGGATACCATCT -39) and olsA-R2 (59-
AACAATGCGGTGGAAGAAAT-39) to amplify a 498- bp
fragment including codons 1 to 47 of the olsA ORF, as well as
357-bp upstream of the olsA start codon and primers olsA-F3
(59ATTTCTTCCACCGCATTGTTACGATGGAAAATCGG-
GTGAG- 39) and olsA-R4 (59-CAGCGCGGAATAGAGTTTTT-
39) to amplify a 372-bp including codons 246 to 268 of the olsA
ORF and 303 bp downstream of the olsA stop codon. Both
fragments were ligated by overlapping PCR using primers olsA-F1
and olsA-R4 and the fragment obtained, containing the deletion
allele, was cloned into pCR2.1 to generate pYLI-2, sequenced to
confirm that the reading frame had been maintained, and
subcloned in pJQ200KS to produce the mutator plasmid pYLI-
3. This plasmid was introduced in BAB-parental and the deletion
mutant generated by allelic exchange was selected by Nal and
sucrose resistance and Gm sensitivity and by PCR using
oligonucleotides olsA-F1 and olsA-R4 which amplify a fragment
of 870 bp in the deletion strain and a fragment of 1464 bp in the
parental strain. The mutation generated results in the loss of
73.8% of the olsA ORF.
For complementation, plasmids carrying olsB and olsA were
constructed using the Gateway cloning Technology (Invitrogen).
Gene olsB was amplified from BAB-parental using primers olsB-
F13 (59 GGGGACAAGTTTGTACAAAAAAGCAGGCTT-
CATGACAGCACTGCTTGGAATGG 39) and gene olsB- R14
(59 GGGGACCACTTTGTACAAGAAAGCTGGGTC CTAG-
ACAAAGCGGTTTGCTTC 39), that contain the attB sequences
(underlined), and cloned into vector pDONR221 (Invitrogen) to
generate pLPI-5. The ORF was subsequently cloned in pRH001
[79], able to multiply in Brucella, to produce the complementation
plasmid pLPI-6. Since the sequence of olsA from B. abortus and B.
melitensis is 99% identical, the clone carrying olsA was extracted
from the B. melitensis ORFEOMA [80] and the ORF subcloned
into plasmid pRH001 [81] to produce plasmid pYLI-1. To
complement the olsB mutation, plasmid pLPI-6 was introduced
into the BABDolsB mutant by mating with E. coli S17 lpir and the
conjugants harboring this plasmid (designated as BABDolsB pLPI-
6) were selected by plating the mating mixture onto tryptic soy
agar-Nal-Km plates. The olsA mutation was complemented
following the same protocol by introducing plasmid pYLI-1 into
the BABDolsA mutant.
Lipid analysis
Total lipids were extracted as described by Bligh and Dyer [82],
and analyzed on silica gel 60 high-performance thin layer
chromatography plates (Merck Chemicals), the plates were pre-
washed by solvent migration with chloroform–methanol-water
(140:60:10, vol/vol), dried thoroughly. Then samples were applied
and chromatography performed in the same mixture of solvents
[83]. Plates were developed with 0.2% ninhydrin in acetone and
heating at 120uC for 5 min or by charring with 15% sulfuric acid
in ethanol at 180uC. L-b,c-dipalmitoyl-a cephalin (Sigma-Aldrich)
was used as a standard.
Sensitivity to non immune serum and complement
consumption
Exponentially growing bacteria were adjusted to 104 CFU/ml
and mixed with fresh sheep normal serum (45 ml of cells plus 90 ml
of serum per well) in microtiter type plates in duplicate. After
incubation for 90 min at 37uC with gentle stirring, brain heart
infusion broth (200 ml/well) was added, mixed and 100 ml aliquots
plated out by triplicate. The results were expressed as the %
survival with respect to the CFU in the inocula. Complement
consumption was estimated as the reduction of the hemolytic
activity of rabbit serum complement incubated with live bacteria,
and S. typhimurium SL1344 was used as a positive control [1].
Infections and bacterial counts in cells
Bone marrow cells were isolated from femurs of 6–10-week-old
C57Bl/6 female mice and differentiated into macrophages [84].
Infections were performed at a multiplicity of infection of 50:1 by
centrifuging bacteria onto macrophages at 400 g for 10 min at 4uC,
followed by a15 min incubation at 37uC under a 5% CO2
atmosphere. Macrophages were extensively washed with Dulbec-
cos’s modified Eagle’s medium to remove extracellular bacteria and
incubated for an additional 90 min in medium supplemented with
50 mg/ml gentamicin to kill extracellular bacteria. Thereafter, the
antibiotic concentration was decreased to 10 mg/ml. At each time
point, samples were washed three times with 100 mM PBS before
processing. Alternatively, murine RAW 264.7 macrophages (Raw
264.7; American Type Culture Collection No. TIB-71) or Hela cells
(American Type Culture Collection No. CCL-2) were used in a
similar protocol. To monitor Brucella intracellular survival, infected
cells were lysed with 0.1% (vol/vol) Triton X-100 in H2O after PBS
washing and serial dilutions of lysates were rapidly plated onto TSB
agar plates to enumerate CFU. The attenuated B. abortus virB
mutant (Table S1) was used as a control.
OL stimulation of macrophages
For macrophage stimulation, OL were included in liposomes.
Total free-lipid extracts of BAB-parental, BABDolsB or a 1:1
mixture of B. pertussis and BABDolsB free-lipids were evaporated
under a nitrogen stream, resuspended thoroughly in 250 ml of
10mM HEPES to a final concentration of 5 mg/ml, and the
composition verified by thin-layer chromatography. Phase contrast
microscopy and fluorescein entrapment controls demonstrated
that Brucella total lipids formed liposomes that were stable for at
least 24 h without addition of exogenous lipids. The murine RAW
264.7 macrophages used in these experiments were grown at 37uC
under 5% CO2 in Dulbecco’s medium supplemented with 10%
fetal bovine serum, 2.5% sodium bicarbonate, 1% glutamine (all
from Gibco), penicillin (100 units/ml) and streptomycin (100 mg/
ml). Macrophages (56105 cells) were treated with 20 mg/mL or
100 mg/mL of liposomes of BAB-parental, BABDolsB or B.
pertussis-BABDolsB in 10% fetal calf serum-Dulbecco’s Modified
Eagle’s Medium. After 90 min of incubation, fresh 10% fetal calf
serum- Dulbeccos’s modified Eagle’s medium was added to obtain
a final concentration of 10 mg/ml and 50 mg/ml of liposomes, and
the amount of TNF-a and IL-6 in the supernatants was assessed by
ELISA (eBioscience) after 6 and 24 h.
Proinflammatory responses in mice
Swiss CD1 mice of 18 to 20 g were used. Fibrin D- dimers were
determined from the plasma of mice 24 h after intraperitoneal
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infection with 0.1 ml of bacteria (16106 UFC/mouse) in pyrogen-
free PBS (pH 7.2). Fibrin D-dimers were assessed by the
semiquantitative D-Di testH latex agglutination assay (Diagnostica
Stago). The levels of IL-6, IL-10, IL-12p40 and TNF-a were
estimated by ELISA (eBioscience) in the sera of mice (n = 5)
infected intraperitoneally with 106 CFU of BABDolsB or BAB-
parental. For leukocyte counts, mice were intraperitoneally
infected with 16106 CFU of BABDolsB or BAB-parental or 105
CFU of S. typhimurium SL1344 in pyrogen-free sterile PBS
(pH 7.2), or with pyrogen-free sterile PBS as a control. Blood
was collected from the retrorbital plexus at different time points in
tubes with 2mg/ml of EDTA. Then, 5 ml of ice cold PBS were
injected in the peritoneal cavity, and 3.0 to 4.5 ml of fluids were
collected with a syringe. After centrifugation, the peritoneal cells
were resuspended in 0.2 ml of PBS, and total leukocytes,
neutrophils, monocytes and lymphocytes were counted. The
number of cells recruited in the peritoneum was corrected
according to the volume of fluid collected from each animal [1].
Virulence and splenomegaly in mice
Groups of 30 mice (seven-week-old female BALB/c mice
[Charles River, Elbeuf, France]) were inoculated intraperitoneally
with 56104 CFU/mouse of BABDolsB or BAB-parental in 0.1 mL
of PBS, and the spleen weights and number of viable bacteria in
spleens were determined in five mice at 2, 6, and 12 weeks post-
inoculation. Experimental procedures (i.e. preparation and
administration of inocula, retrospective assessment of the exact
inoculating doses, and determination of the number of CFU/
spleen) were performed as described previously [85]. The identity
of the spleen isolates was confirmed by PCR amplification at each
selected post-inoculation point time. Spleen weights were ex-
pressed as the mean and SD (n = 5) of grams/spleen and infections
as mean 6 SD (n = 5) of log10 CFU/spleen at each selected post-
inoculation point-time, previous logarithmic normalization of
individual data. Statistical comparisons between means were
performed by ANOVA and the Fisher’s Protected Least
Significant Differences test [86].
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